0001209191-15-072320.txt : 20150928 0001209191-15-072320.hdr.sgml : 20150928 20150928171525 ACCESSION NUMBER: 0001209191-15-072320 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150924 FILED AS OF DATE: 20150928 DATE AS OF CHANGE: 20150928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 38 SIDNEY STREET STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-272-5275 MAIL ADDRESS: STREET 1: 38 SIDNEY STREET STREET 2: 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goddard Glenn CENTRAL INDEX KEY: 0001581992 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 151128181 MAIL ADDRESS: STREET 1: C/O AGIOS PHARMACEUTICALS, INC. STREET 2: 38 SIDNEY STREET, 2ND FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-09-24 0 0001439222 AGIOS PHARMACEUTICALS INC AGIO 0001581992 Goddard Glenn C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Senior Vice President, Finance Common stock 2015-09-24 4 M 0 10000 A 10000 D Common stock 2015-09-24 4 F 0 4856 88.89 D 5144 D Common stock 2015-09-24 4 M 0 856 23.10 A 6000 D Common stock 2015-09-24 4 S 0 6000 85.97 D 0 D Restricted stock units 2015-09-24 4 M 0 10000 0.00 D Common stock 10000 0 D Stock option (right to buy) 23.10 2015-09-24 4 M 0 856 0.00 D 2023-08-27 Common stock 856 88242 D Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $85.09 to $87.70. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. The restricted stock units were granted on September 24, 2014 and vested in full on September 24, 2015. This option was granted on August 28, 2013. The shares underlying this option vest as to 25% of the underlying shares on August 28, 2014, with the remaining 75% vesting in 36 equal monthly installments thereafter. /s/ Glenn Goddard 2015-09-28